本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Checkmate Pharmaceuticals

10.50
0.0000
成交量:- -
成交額:66.80萬
市值:2.31億
市盈率:-3.60
高:10.50
開:10.50
低:10.50
收:10.50
52周最高:10.50
52周最低:2.00
股本:2,203.82萬
流通股本:652.09萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.9195
每股收益(LYR):-2.8407
淨資產收益率:-75.44%
總資產收益率:-42.31%
市淨率:4.21
市盈率(LYR):-3.70

資料載入中...

2022/06/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/06/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/06/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/31

重要事件披露

8-K - Current report
2022/05/31

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/05/31

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/05/31

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/05/31

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/05/12

重要事件披露

8-K - Current report
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/04/29

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/04/19

重要事件披露

8-K - Current report
2022/04/19

重要事件披露

8-K - Current report
2022/03/30

重要事件披露

8-K - Current report
2022/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/01

重要事件披露

8-K - Current report